Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study